Literature DB >> 8760827

The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C.

L D Barber1, L Percival, N M Valiante, L Chen, C Lee, J E Gumperz, J H Phillips, L L Lanier, J C Bigge, R B Parekh, P Parham.   

Abstract

The vast majority of new human HLA class I alleles are formed by conversions between existing alleles of the same locus. A notable exception to this rule is HLA-B*4601 formed by replacement of residues 66-76 of the alpha 1 helix of B*1501 by the homologous segment of Cw*0102. This inter-locus recombination, which brings together characteristic elements of HLA-B and HLA-C structure, is shown here to influence function dramatically. Naturally processed peptides bound by B*4601 are distinct from those of its parental allotypes B*1501 and Cw*0102 and dominated by three high abundance peptides. Such increased peptide selectivity by B*4601 is unique among HLA-A,B,C allotypes. For other aspects of function, presence of the small segment of HLA-C-derived sequence in an otherwise HLA-B framework converts B*4601 to an HLA-C-like molecule. Alloreactive cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and cellular glycosidases all recognize B*4601 as though it were an HLA-C allotype. These unusual properties are those of an allotype which has frequencies as high as 20% in south east Asian populations and is associated with predisposition to autoimmune diseases and nasopharyngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760827      PMCID: PMC2192697          DOI: 10.1084/jem.184.2.735

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes.

Authors:  J Zemmour; J E Gumperz; W H Hildebrand; F E Ward; S G Marsh; R C Williams; P Parham
Journal:  Tissue Antigens       Date:  1992-05

2.  Accurate prediction of the stability and activity effects of site-directed mutagenesis on a protein core.

Authors:  C Lee; M Levitt
Journal:  Nature       Date:  1991-08-01       Impact factor: 49.962

3.  Structure and expression of a human gene coding for a 71 kd heat shock 'cognate' protein.

Authors:  B Dworniczak; M E Mirault
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

4.  Japanese Graves' disease: association with HLA-Bw46.

Authors:  S Naito; H Sasaki; K Arakawa
Journal:  Endocrinol Jpn       Date:  1987-10

5.  HLA and nasopharyngeal carcinoma in Chinese--a further study.

Authors:  S H Chan; N E Day; N Kunaratnam; K B Chia; M J Simons
Journal:  Int J Cancer       Date:  1983-08-15       Impact factor: 7.396

6.  Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese.

Authors:  B R Hawkins; J T Ma; K S Lam; C C Wang; R T Yeung
Journal:  Clin Endocrinol (Oxf)       Date:  1985-09       Impact factor: 3.478

7.  Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma.

Authors:  M J Simons; G B Wee; S H Chan; K Shanmugaratnam
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

8.  HLA and thyrotoxicosis (Graves' disease) in Chinese.

Authors:  S H Chan; P P Yeo; K F Lui; G B Wee; K T Woo; P Lim; J S Cheah
Journal:  Tissue Antigens       Date:  1978-08

9.  Unusual uniformity of the N-linked oligosaccharides of HLA-A, -B, and -C glycoproteins.

Authors:  L D Barber; T P Patel; L Percival; J E Gumperz; L L Lanier; J H Phillips; J C Bigge; M R Wormwald; R B Parekh; P Parham
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.

Authors:  J Zemmour; P Parham
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  32 in total

1.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

2.  Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.

Authors:  F Zappacosta; F Borrego; A G Brooks; K C Parker; J E Coligan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Peptide antagonism as a mechanism for NK cell activation.

Authors:  Lena Fadda; Gwenoline Borhis; Parvin Ahmed; Kuldeep Cheent; Sophie V Pageon; Angelica Cazaly; Stavros Stathopoulos; Derek Middleton; Arend Mulder; Frans H J Claas; Tim Elliott; Daniel M Davis; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

4.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.

Authors:  Rajan P Nair; Philip E Stuart; Ioana Nistor; Ravi Hiremagalore; Nicholas V C Chia; Stefan Jenisch; Michael Weichenthal; Gonçalo R Abecasis; Henry W Lim; Enno Christophers; John J Voorhees; James T Elder
Journal:  Am J Hum Genet       Date:  2006-03-31       Impact factor: 11.025

5.  Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.

Authors:  J K Orleans-Lindsay; L D Barber; H G Prentice; M W Lowdell
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 6.  Primate-specific regulation of natural killer cells.

Authors:  Peter Parham; Laurent Abi-Rached; Lilit Matevosyan; Achim K Moesta; Paul J Norman; Anastazia M Older Aguilar; Lisbeth A Guethlein
Journal:  J Med Primatol       Date:  2010-08       Impact factor: 0.667

Review 7.  Co-evolution of MHC class I and variable NK cell receptors in placental mammals.

Authors:  Lisbeth A Guethlein; Paul J Norman; Hugo G Hilton; Peter Parham
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

8.  Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.

Authors:  Laurent Abi-Rached; Achim K Moesta; Raja Rajalingam; Lisbeth A Guethlein; Peter Parham
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

9.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Fotini Partheniou; Ann-Margaret Little; Peter Parham
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

10.  Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes.

Authors:  Valerie A Walshe; Channa K Hattotuwagama; Irini A Doytchinova; Mailee Wong; Isabel K Macdonald; Arend Mulder; Frans H J Claas; Pierre Pellegrino; Jo Turner; Ian Williams; Emma L Turnbull; Persephone Borrow; Darren R Flower
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.